Trial Profile
A Multicenter, Randomized, Controlled, Double-Blind, Double-Dummy, Two-Arm Study of Posaconazole vs Fluconazole in the Treatment of Coccidioidomycosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary) ; Fluconazole
- Indications Coccidioidomycosis
- Focus Adverse reactions
- Acronyms Study P04558Am1
- Sponsors Merck Sharp & Dohme
- 13 Mar 2015 New trial record